Abbott Laboratories snaps six straight sessions of losses
Abbott Laboratories (ABT) shares snapped six straight sessions of losses, as the stock closed 1.2% higher at $108.77 on...
Tag: ABT
Abbott CEO purchases $2M worth of company shares
Abbott Laboratories (ABT) Chairman and CEO Robert Ford purchased 18.8K of company stock recently with a value of just over...
Abbott projects 7% organic sales growth and 10% EPS rise for 2026 as Nutrition pivots to volume recovery
Earnings Call Insights: Abbott Laboratories (ABT) Q4 2025 CEO Robert Ford highlighted that 2025 showcased "Abbott's...
Abbott drops as Nutrition unit drives Q4 revenue miss
Abbott Laboratories (ABT) lost ~5% in the premarket on Thursday after the MedTech giant reported lower-than-expected revenue...
Earnings Snapshot: Abbott Laboratories Q4 beats profit estimates, but misses on revenue; initiates Q1 and FY26 outlook
*Other Operating Data Consensus Source: Bloomberg Abbott Laboratories: Q4 Earnings On The Horizon Abbott: Not Cheap, But...
Abbott Laboratories Non-GAAP EPS of $1.50 beats by $0.01, revenue of $11.46B misses by $340M
Abbott Laboratories press release (ABT): Q4 Non-GAAP EPS of $1.50 beats by $0.01. Revenue of $11.46B (+4.5% Y/Y) misses by...
Abbott Laboratories Q4 2025 Earnings Preview
Abbott Laboratories (ABT) is scheduled to announce Q4 earnings results on Thursday, January 22nd, before market open. The...
Abbott wins FDA approval of Volt pulsed ablation device for atrial fibrillation
The US FDA has granted approval of Abbott Laboratories (ABT) Volt Pulsed Field Ablation System to treat atrial...
FDA making use of real-world evidence in device applications easier
The US FDA will no longer require that identifiable individual patient data be required from applicants when submitting...